MeSH term
Frequency | Condition_Probility | Female | 34 | 0.0 |
Humans | 66 | 0.0 |
Immunohistochemistry | 8 | 0.0 |
Lymphatic Metastasis/*pathology | 2 | 5.0 |
Research Support, Non-U.S. Gov't | 30 | 0.0 |
Axilla | 8 | 12.0 |
Lymph Nodes/pathology | 4 | 1.0 |
Middle Aged | 25 | 0.0 |
*Sentinel Lymph Node Biopsy | 9 | 45.0 |
Breast Neoplasms/*pathology | 4 | 1.0 |
Lymph Node Excision | 7 | 9.0 |
Lymphatic Metastasis | 10 | 0.0 |
Predictive Value of Tests | 4 | 0.0 |
Biopsy | 2 | 0.0 |
Lymphatic Metastasis/*radionuclide imaging | 2 | 50.0 |
Neoplasm Staging | 8 | 0.0 |
Radiopharmaceuticals/*diagnostic use | 2 | 4.0 |
Sentinel Lymph Node Biopsy | 4 | 30.0 |
Adult | 24 | 0.0 |
Aged | 19 | 0.0 |
Aged, 80 and over | 9 | 0.0 |
Breast Neoplasms/*pathology/surgery | 2 | 12.0 |
Feasibility Studies | 2 | 0.0 |
Follow-Up Studies | 2 | 0.0 |
Lymph Nodes/*pathology/radionuclide imaging | 2 | 66.0 |
Prognosis | 2 | 0.0 |
Sentinel Lymph Node Biopsy/*methods | 3 | 37.0 |
Sensitivity and Specificity | 6 | 0.0 |
Male | 25 | 0.0 |
Radiopharmaceuticals/diagnostic use | 2 | 3.0 |
Technetium Tc 99m Aggregated Albumin/diagnostic use | 2 | 33.0 |
Lymph Nodes/pathology/*radionuclide imaging | 2 | 40.0 |
Preoperative Care | 2 | 1.0 |
Animals | 11 | 0.0 |
Mice | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
Dyes | 2 | 1.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Reference Values | 3 | 0.0 |
Molecular Sequence Data | 3 | 0.0 |
Adolescent | 4 | 0.0 |
Child | 5 | 0.0 |
Child, Preschool | 4 | 0.0 |
Multivariate Analysis | 2 | 0.0 |
Infant | 5 | 0.0 |
Parkinson Disease/*metabolism | 2 | 7.0 |
English Abstract | 4 | 0.0 |
Lymph Node Excision/*methods | 2 | 20.0 |
Cell Line | 3 | 0.0 |
Immunoblotting | 2 | 0.0 |
Rats | 4 | 0.0 |
Comparative Study | 7 | 0.0 |
Electrocardiography | 6 | 1.0 |
Pacemaker, Artificial | 2 | 16.0 |
Cell Division/drug effects | 2 | 0.0 |
Cell Movement/drug effects | 2 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Neuropeptides/*pharmacology | 2 | 3.0 |
Time Factors | 3 | 0.0 |
Interferon Type II/*pharmacology | 2 | 0.0 |
Atrioventricular Node/*physiopathology | 2 | 8.0 |
Cardiac Pacing, Artificial | 3 | 6.0 |
*Heart Transplantation | 3 | 3.0 |
*Postoperative Complications | 3 | 4.0 |
Sinoatrial Node/*physiopathology | 6 | 42.0 |
Electrophysiology | 5 | 1.0 |
Heart Rate | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Sick Sinus Syndrome/*physiopathology | 2 | 50.0 |
Sinoatrial Block/physiopathology | 2 | 66.0 |
Kinetics | 2 | 0.0 |
Prospective Studies | 2 | 0.0 |
*Glomerular Filtration Rate | 3 | 12.0 |
Pentetic Acid/*diagnostic use | 2 | 66.0 |
Technetium/*diagnostic use | 5 | 20.0 |
